Infectious disease. New weapons in the battle of the bugs.
Ferber
Dan
D
D000581:Amidohydrolases; D000626:Aminopeptidases / Q000037:antagonists & inhibitors; D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D014355:Chagas Disease / Q000188:drug therapy / Q000469:parasitology; D004269:DNA, Bacterial / Q000378:metabolism; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004875:Ergosterol / Q000096:biosynthesis; D006095:Gram-Positive Cocci / Q000187:drug effects; D006571:Heterocyclic Compounds / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D011401:Promoter Regions, Genetic; D014344:Trypanocidal Agents / Q000494:pharmacology; D014349:Trypanosoma cruzi / Q000187:drug effects* / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000924:Anticholesteremic Agents; D004269:DNA, Bacterial; D004791:Enzyme Inhibitors; D006571:Heterocyclic Compounds; D014344:Trypanocidal Agents; D000626:Aminopeptidases; D000581:Amidohydrolases; C084507:peptide deformylase; D004875:Ergosterol